MyAverix Finance
SHG · Healthcare
Shanghai Rendu Biotechnology Co. Ltd. A (688193)
Diagnostics & Research
Shanghai Rendu Biotechnology Co. Ltd. A (688193) is listed on SHG in the Healthcare sector. Industry: Diagnostics & Research. As of 2026-03-29, reported market cap is $2.05B, P/E ratio is 18.00, net margin is 5.9%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 688193
Shanghai Rendu Biotechnology Co. Ltd. A (688193) — FAQ
What is Shanghai Rendu Biotechnology Co. Ltd. A's market cap?
Shanghai Rendu Biotechnology Co. Ltd. A (688193) has a reported market cap of $2.05B (data as of 2026-03-29).
What is 688193's P/E ratio?
The price-to-earnings (P/E) ratio for Shanghai Rendu Biotechnology Co. Ltd. A (688193) is 18.00 (data as of 2026-03-29).
Does Shanghai Rendu Biotechnology Co. Ltd. A pay a dividend?
Dividend yield is not available in the current snapshot for Shanghai Rendu Biotechnology Co. Ltd. A (688193). Check the MyAverix Finance app for the latest dividend data.
What sector is Shanghai Rendu Biotechnology Co. Ltd. A in?
Shanghai Rendu Biotechnology Co. Ltd. A (688193) is classified in the Healthcare sector (Diagnostics & Research industry).
What exchange is 688193 listed on?
688193 is listed on SHG.
What is Shanghai Rendu Biotechnology Co. Ltd. A's net margin?
Shanghai Rendu Biotechnology Co. Ltd. A (688193) reports a net margin of 5.9% (data as of 2026-03-29).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.